LU72439A1 - - Google Patents

Info

Publication number
LU72439A1
LU72439A1 LU72439A LU72439A LU72439A1 LU 72439 A1 LU72439 A1 LU 72439A1 LU 72439 A LU72439 A LU 72439A LU 72439 A LU72439 A LU 72439A LU 72439 A1 LU72439 A1 LU 72439A1
Authority
LU
Luxembourg
Application number
LU72439A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to LU72439A priority Critical patent/LU72439A1/xx
Priority to BE165217A priority patent/BE839625A/fr
Publication of LU72439A1 publication Critical patent/LU72439A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU72439A 1975-05-09 1975-05-09 LU72439A1 (sl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LU72439A LU72439A1 (sl) 1975-05-09 1975-05-09
BE165217A BE839625A (fr) 1975-05-09 1976-03-16 Procede pour l'enrobage enterique de medicaments ainsi enrobes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU72439A LU72439A1 (sl) 1975-05-09 1975-05-09

Publications (1)

Publication Number Publication Date
LU72439A1 true LU72439A1 (sl) 1977-02-09

Family

ID=19727929

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72439A LU72439A1 (sl) 1975-05-09 1975-05-09

Country Status (2)

Country Link
BE (1) BE839625A (sl)
LU (1) LU72439A1 (sl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419722A1 (fr) * 1978-03-13 1979-10-12 Bayer Italia Spa Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus
FR2476485A1 (fr) * 1980-02-26 1981-08-28 Roussel Uclaf Nouveau procede d'enrobage d'au moins un principe actif medicamenteux, les nouveaux medicaments ainsi obtenus, et les compositions les renfermant

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419722A1 (fr) * 1978-03-13 1979-10-12 Bayer Italia Spa Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus
FR2476485A1 (fr) * 1980-02-26 1981-08-28 Roussel Uclaf Nouveau procede d'enrobage d'au moins un principe actif medicamenteux, les nouveaux medicaments ainsi obtenus, et les compositions les renfermant
EP0036345A1 (fr) * 1980-02-26 1981-09-23 Roussel-Uclaf Nouveau procédé d'enrobage d'au moins un principe actif médicamenteux, les nouveaux médicaments ainsi obtenus, et les compositions les renfermant

Also Published As

Publication number Publication date
BE839625A (fr) 1976-07-16

Similar Documents

Publication Publication Date Title
FR2313680B1 (sl)
FR2308727B3 (sl)
FR2321636B1 (sl)
FR2312298B2 (sl)
JPS528034U (sl)
JPS5257022U (sl)
JPS5235685U (sl)
JPS5227670U (sl)
JPS51100824U (sl)
CH606588A5 (sl)
CH599693A5 (sl)
CH606876A5 (sl)
CH598557A5 (sl)
CH605287A5 (sl)
CH605132A5 (sl)
CH604955A5 (sl)
CH604662A5 (sl)
CH604481A5 (sl)
BG22878A1 (sl)
BG22763A1 (sl)
CH604367A5 (sl)
BG22493A1 (sl)
CH603734A5 (sl)
CH603083A5 (sl)
CH603079A5 (sl)